A update on my very surprising results when combining Ibrutinib + Idelalisib + Venetoclax.
Initial Post with more detail:
healthunlocked.com/cllsuppo....
I just had a second Bone Marrow biopsy after about 8 weeks on this "triple combo" after the surprisingly positive result of the first BM we lowered the doses to 140mg Ibrutinib + 2x150mg Idelalisib + 100mg Venetoclax / day to mitigate toxicity. The result remains and now there is 0.27% CLL in the BM biopsy, still no trace of Richter's.
In the complete report from the initial BM biopsy/aspiration I have two results. One is labeled as "Peripheral blood" with 6.5% and the other is labelled BM biopsy with 0.34%. They did not mention any test of Pheripheral blood at this point so it might be mislabeled. I hope to have this clarified on next appointment. Around the same time as this first BM (3 weeks after starting triple combo) I had a separate flow cytometry from pheiripheral blood that shows 0% CLL.
So it was either 6.5% or 0.34% CLL with no trace of RT in BM after the first three weeks. The important factor for me is that the effect is remaining at a lower dose, as the normal bone marrow function was very suppressed at the original dose. BM Function is still suppressed with current dosage, but seems to still slooowly be improving. Will have a PET next week to confirm there is no new activity in Lymph Nodes.
I have had a few different opinions from doctors on what is the best direction going forward.
1. Straight for a new Bone Marrow Transplant.
2. Try DLI if there is no sign of GvHD (I have a slight rash on the arm). If DLI is not applicable or giving response go for second transplant.
3. Try to consolidate current response with DLI, then move to second transplant, seemingly also if disease responds to DLI.
DLI consists of infusing T Cells from the donor for the first transplant, doctors are checking if he is available / willing to donate. There seems to not be much data for efficacy of DLI with CLL/RT. To me it seems natural to try to utilise the first transplant to its full potential before moving to a new bone marrow transplant. Less invasive treatment would be nice, but a potential cure is far more important.
Always a decision to make
Gunnar